Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
What is your approach to a patient with incidentally found DCIS or invasive disease after a breast reduction?
Generally, the margins are uncertain in this scenario and re-excision is usually not possible.
Answer from: Radiation Oncologist at Academic Institution
Typically, in these cases I will give standard whole breast irradiation (40/15). I have not boosted as it's often unclear where the boost target is.
Comments
Radiation Oncologist at Blanchard Valley Hospital
Thank you - how do you address the axilla in cases...
Radiation Oncologist at Cleveland Clinic
For DCIS, don't routinely push for SLN. For invasi...
Radiation Oncologist at Varian Medical Systems/Allegheny health network
Sometimes for these small incidentally diagnosed l...
Radiation Oncologist at Naval Medical Center San Diego
I have a male patient in his 20s with bilateral G1...
Radiation Oncologist at Cleveland Clinic
I would wait for genetics; if BRCA mutation, would...
Radiation Oncologist at Naval Medical Center San Diego
Margins negative but close <1 mm bilaterally (n...
Radiation Oncologist at Cleveland Clinic
I would think so, there is not a lot of data on th...
Radiation Oncologist at Naval Medical Center San Diego
Thanks!
2341
2343
2344
13755
13760
13761
13771
13774
Sign in or Register to read more
6764
Related Questions
Do you start systemic therapy for patients with previously localized HR+ breast cancer developing solitary bone metastasis which is now triple negative if there are no other sites of disease after metastasis-directed radiation?
How would you manage a patient presenting with recurrent cT4 breast cancer?
In which scenarios do you stage breast cancer using CT and nuclear bone scans versus PET-CT?
When treating APBI with the Florence regimen, are you using daily or every other day fractionation?
In patients with HER-2 positive breast cancer on pertuzumab/trastuzumab with newly developed asymptomatic brain metastases only, do you wait 3 weeks after administration of the targeted therapy to deliver SRS?
When evaluating for PMRT in patients who did not receive neoadjuvant chemotherapy and are found to be pN0, do you utilize clinical T-staging, or pathologic T-staging?
Would you offer a patient with “good-risk” DCIS and an elevated DCISionRT score APBI or WBI?
In patients with history of prior axillary surgery, subsequently with breast cancer recurrence, and sentinel lymph nodes mapped to internal mammary area (but were not biopsied), do you offer post-mastectomy radiation to cover the IMNs?
Do you recommend adjuvant RT to patients with non-ATM genetic mutations (e.g. BRCA, NF) who elect to have lumpectomy and are otherwise PRIME II/CALGB candidates for RT omission (i.e. low risk disease characteristics: strongly ER+, <1cm, grade 1-2, no LVI, widely negative margins, and committed to endocrine therapy)?
Would you consider once weekly radiation with a simultaneous integrated boost for a patient with node negative breast cancer with a positive margin for whom reexcision is not an option?
Thank you - how do you address the axilla in cases...
For DCIS, don't routinely push for SLN. For invasi...
Sometimes for these small incidentally diagnosed l...
I have a male patient in his 20s with bilateral G1...
I would wait for genetics; if BRCA mutation, would...
Margins negative but close <1 mm bilaterally (n...
I would think so, there is not a lot of data on th...
Thanks!